Business Description
CryoPort Inc
NAICS : 484110
SIC : 4783
ISIN : US2290503075
Description
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.08 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.88 | |||||
| Debt-to-EBITDA | -5.25 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -0.11 | |||||
| Beneish M-Score | -3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 32.9 | |||||
| 3-Year EBITDA Growth Rate | -37.3 | |||||
| 3-Year EPS without NRI Growth Rate | 5.2 | |||||
| 3-Year FCF Growth Rate | -13.8 | |||||
| 3-Year Book Growth Rate | -0.3 | |||||
| Future 3-5Y Total Revenue Growth Rate | 7.92 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 9.07 | |||||
| 9-Day RSI | 13.92 | |||||
| 14-Day RSI | 18.28 | |||||
| 6-1 Month Momentum % | -33.63 | |||||
| 12-1 Month Momentum % | -40.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.73 | |||||
| Quick Ratio | 10.22 | |||||
| Cash Ratio | 9.16 | |||||
| Days Inventory | 75.59 | |||||
| Days Sales Outstanding | 69.62 | |||||
| Days Payable | 75.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.1 | |||||
| Shareholder Yield % | 4.35 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.79 | |||||
| Operating Margin % | -34.14 | |||||
| Net Margin % | -50.18 | |||||
| FCF Margin % | -20.55 | |||||
| ROE % | -21.68 | |||||
| ROA % | -11.34 | |||||
| ROIC % | -15.75 | |||||
| ROC (Joel Greenblatt) % | -71.98 | |||||
| ROCE % | -11.31 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.4 | |||||
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 2.08 | |||||
| EV-to-EBIT | -2.88 | |||||
| EV-to-Forward-EBIT | -4.36 | |||||
| EV-to-EBITDA | -3.91 | |||||
| EV-to-Forward-EBITDA | -7.64 | |||||
| EV-to-Revenue | 1.38 | |||||
| EV-to-Forward-Revenue | 1.28 | |||||
| EV-to-FCF | -6.69 | |||||
| Price-to-Projected-FCF | 5.15 | |||||
| Price-to-Median-PS-Value | 0.16 | |||||
| Price-to-Net-Current-Asset-Value | 11.44 | |||||
| Earnings Yield (Greenblatt) % | -34.72 | |||||
| FCF Yield % | -15.19 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers